Egetis Therapeutics AB (publ) (OM:EGTX) Commented on Market Rumors. Egetis Has Ongoing Discussions with Certain External Parties Regarding A Potential Acquisition of Company. There Can Be No Certainty That A Public Take-Over Offer Will Be Made, Nor as to Terms of Any Such Offer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.79 SEK | +1.04% | +8.29% | +21.68% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.68% | 184M | |
+7.60% | 113B | |
+11.19% | 106B | |
+0.41% | 22.27B | |
-11.86% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.91% | 17.24B | |
+7.03% | 14.29B | |
+35.73% | 12.52B |
- Stock Market
- Equities
- EGTX Stock
- News Egetis Therapeutics AB
- Egetis Comments on M&A Rumors